After the presentation, each participant will:

• Discuss the effects of a Factor Xia inhibitor added to usual care for secondary prevention after ischemic stroke or high-risk TIA
• Compare the outcomes of thrombectomy plus IV alteplase versus thrombectomy alone in patients with LVO
• Compare the outcomes of patients who were or were not treated with Tenecteplase 4.5-24 hours after non-LVO AIS
• Discuss the use of a recombinant Factor VIIa in patients with acute parenchymal ICH
• Compare the outcomes of infants with perinatal arterial ischemic stroke who were treated with two doses of CIMT with those treated with usual care

Disclosure of Financial Interest Summary

All planners, faculty, and others in control of educational content are required to disclose all their financial relationships with ineligible companies within the prior 24 months. An ineligible company is defined as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company.

Larry B. Goldstein, MD, FAAN, FANA, FAHA speaker for this event, has a financial relationship with Janssen. He is the chair of DSMB.

All of the relevant financial relationships listed for these individuals have been mitigated.

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.
Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.